TORONTO, ON / ACCESSWIRE / January 2, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release.
Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Shares of Intellipharmaceutics International Inc. (OTCMKTS:IPCIF – Get Free Report) (TSE:I) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.06 and traded as high as $0.06. Intellipharmaceutics International shares last traded at $0.04, with a volume of 14,730 shares changing […]